SE8600496L - Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider - Google Patents

Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider

Info

Publication number
SE8600496L
SE8600496L SE8600496A SE8600496A SE8600496L SE 8600496 L SE8600496 L SE 8600496L SE 8600496 A SE8600496 A SE 8600496A SE 8600496 A SE8600496 A SE 8600496A SE 8600496 L SE8600496 L SE 8600496L
Authority
SE
Sweden
Prior art keywords
dihydroergotal
kaloids
pharmaceutical compositions
compositions containing
dihydroergotamine
Prior art date
Application number
SE8600496A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8600496D0 (sv
Inventor
O Zuger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8600496D0 publication Critical patent/SE8600496D0/xx
Publication of SE8600496L publication Critical patent/SE8600496L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8600496A 1985-02-05 1986-02-04 Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider SE8600496L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (2)

Publication Number Publication Date
SE8600496D0 SE8600496D0 (sv) 1986-02-04
SE8600496L true SE8600496L (sv) 1986-08-06

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8600496A SE8600496L (sv) 1985-02-05 1986-02-04 Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider

Country Status (24)

Country Link
JP (1) JPS61183225A (hu)
KR (1) KR920010388B1 (hu)
AU (1) AU597570B2 (hu)
BE (1) BE904152A (hu)
CA (1) CA1263087A (hu)
CH (1) CH667592A5 (hu)
CY (1) CY1604A (hu)
DE (1) DE3602577A1 (hu)
DK (1) DK167138B1 (hu)
ES (1) ES8800040A1 (hu)
FR (1) FR2576787B1 (hu)
GB (1) GB2170407B (hu)
GR (1) GR860310B (hu)
HK (1) HK57191A (hu)
HU (1) HU195729B (hu)
IE (1) IE59293B1 (hu)
IT (1) IT1191255B (hu)
LU (1) LU86289A1 (hu)
NL (1) NL8600161A (hu)
NZ (1) NZ215020A (hu)
PH (1) PH23384A (hu)
PT (1) PT81954B (hu)
SE (1) SE8600496L (hu)
SG (1) SG56191G (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
CA2393344C (en) * 1999-12-03 2009-09-01 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
DE60132444T2 (de) 2000-05-12 2009-01-22 Meracol Corp. Ltd., Takapuna Behandlung von reizkolon-syndrom oder -krankheit
ES2298237T3 (es) * 2000-05-12 2008-05-16 Meracol Corporation Limited Cetil miristato y cetil palmitato para el tratamiento del eczema y/o de la soriasis.
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
DK167138B1 (da) 1993-09-06
HUT41984A (en) 1987-06-29
LU86289A1 (fr) 1986-09-02
IE59293B1 (en) 1994-02-09
CH667592A5 (de) 1988-10-31
IT1191255B (it) 1988-02-24
PT81954B (pt) 1988-07-01
BE904152A (fr) 1986-08-04
SG56191G (en) 1991-08-23
FR2576787B1 (fr) 1990-01-12
GR860310B (en) 1986-05-27
HK57191A (en) 1991-08-02
GB2170407A (en) 1986-08-06
CY1604A (en) 1992-04-03
GB2170407B (en) 1988-10-26
KR860006265A (ko) 1986-09-09
NZ215020A (en) 1989-07-27
JPS61183225A (ja) 1986-08-15
IT8647620A0 (it) 1986-02-05
IE860291L (en) 1986-08-05
KR920010388B1 (ko) 1992-11-27
DE3602577A1 (de) 1986-08-28
AU5294286A (en) 1986-08-14
CA1263087A (en) 1989-11-21
HU195729B (en) 1988-07-28
DK52086A (da) 1986-08-06
DK52086D0 (da) 1986-02-03
NL8600161A (nl) 1986-09-01
PT81954A (en) 1986-03-01
ES8800040A1 (es) 1987-10-16
ES551635A0 (es) 1987-10-16
AU597570B2 (en) 1990-06-07
GB8602602D0 (en) 1986-03-12
FR2576787A1 (fr) 1986-08-08
PH23384A (en) 1989-07-26
SE8600496D0 (sv) 1986-02-04

Similar Documents

Publication Publication Date Title
DE3379496D1 (en) Constant release rate solid oral dosage formulations of cardiovascular drugs
AU5159490A (en) Composition and method for administration of pharmaceutically active substances
GR1003711B (el) Μεθοδος δια την παρασκευη φαρμακευτικων συνθεσεων δια συστηματικην διαδερμικην χορηγησιν.
EG20219A (en) Method of preparation of deiwatives indole used in preparation of pharmaceutical composition and treatment of migraine
AU3284984A (en) Pharmaceutical compositions for the transdermal application of active ingredients
PL287200A1 (en) Method of making a sticking plaster with an estrogen containing active substance incorporated into adhesive layer thereof
EA199600029A3 (ru) Оральная композиция, содержащая s (+)-этодолак, способ её получения
EP0177342A3 (en) Oral formulation of therapeutic proteins
SE8600496L (sv) Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider
IL92797A0 (en) Therapeutical active substituted benzimidazole and process for its preparation
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
DE69824853D1 (de) Zusammensetzungen und gegenstände zur verminderung der auswirkung von entzündungen
JPS5781409A (en) External plaster
EP0236002A3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
EP0403530A4 (en) Storage-stable compositions and methods for treating keratinous tissue
EP0351876A3 (en) Composition for potentiating vaccination effect
CO5031290A1 (es) Formulacion lo
EP0539516A4 (hu)
EP0367509A3 (en) Formulations
HUT43235A (en) Insecticidal compositions comprising 2-(benzofuran-7-yl)-hydrazinecarboxylic acid ester derivatives as active substance and process for preparing the active substances
PT968717E (pt) Preparacao sob a forma galenica simples visando limitar os efeitos ocorridos durante a menopausa, e posteriormente, e tratamento com esta preparacao
ITMI913248A1 (it) Composizioni terapeutiche adatte per la somministrazione orale contenenti come principio attivo uno o piu' tioesteri del glutatione e procedimento per la preparazione dei suddetti principi attivi

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8600496-7

Effective date: 19940426